American Journal of Clinical Nutrition, Vol 67, 669-684, Copyright © 1998 by The American Society for Clinical Nutrition, Inc

ORIGINAL RESEARCH COMMUNICATIONS

Human plasma and tissue alpha-tocopherol concentrations in response to supplementation with deuterated natural and synthetic vitamin E

GW Burton, MG Traber, RV Acuff, DN Walters, H Kayden, L Hughes and KU Ingold
Steacie Institute for Molecular Sciences, National Research Council of Canada, Ottawa, Ontario. gburton@ned1.sims.nrc.ca

We report a comparison of natural and synthetic vitamin E in humans using deuterium labeling to permit the two forms of vitamin E to be measured independently in plasma and tissues of each subject. Differences in natural and synthetic vitamin E concentrations were measured directly under equal dosage conditions using an equimolar mixture of deuterated RRR-alpha-tocopheryl acetate and all-rac-alpha- tocopheryl acetate. Two groups of five adults took 30 mg of the mixture as a single dose and as eight consecutive daily doses, respectively. After a 1-mo interval the schedule was repeated but with a 10-fold higher dose (ie, 300 mg). In each case, the ratio of plasma d3-RRR- alpha-tocopherol to d6-all-rac-alpha-tocopherol (RRR:rac) increased from approximately 1.5-1.8 to approximately 2 after dosing ended. In an elective surgery study in which 22 patients were given 150 mg/d for up to 41 d before surgery, the RRR:rac in tissues was lower than in plasma and the percentage of deuterated alpha-tocopherol was lower in all tissues except gallbladder and liver. In a terminally ill patient given 30 mg/d for 361 d, plasma and tissue (x+/-SD) RRR-rac ratios (and % deuterated alpha-tocopherol) at autopsy were 2.06 (6.3%) and 1.71+/- 0.24 (5.9+/-2.2%), respectively. In a second terminally ill patient given 300 mg/d for 615 d, the corresponding values were 2.11 (68%) and 2.01+/-0.17 (65+/-10%), respectively. The results indicated that natural vitamin E has roughly twice the availability of synthetic vitamin E. This 2:1 ratio is significantly higher than the currently accepted RRR:rac of 1.36:1.00. Gamma-Tocopherol, expressed as a fraction of total unlabeled tocopherols in 15 elective surgery patients, was 1.4-4.6 (mean: 2.6) times greater in adipose tissue, muscle, skin, and vein than in plasma, which is a substantially larger fraction than had been recognized previously.

This article has been cited by other articles:

				S.-K. Park, G. P. Page, K. Kim, D. B. Allison, M. Meydani, R. Weindruch, and T. A. Prolla {alpha}- and {gamma}-Tocopherol Prevent Age-Related Transcriptional Alterations in the Heart and Brain of Mice J. Nutr., June 1, 2008; 138(6): 1010 - 1018. [Abstract] [Full Text] [PDF]

				E. Brignardello, C. Runzo, M. Aragno, M. G. Catalano, M. Cassader, P. C. Perin, and G. Boccuzzi Dehydroepiandrosterone Administration Counteracts Oxidative Imbalance and Advanced Glycation End Product Formation in Type 2 Diabetic Patients Diabetes Care, November 1, 2007; 30(11): 2922 - 2927. [Abstract] [Full Text] [PDF]

				S. A. Talegawkar, E. J. Johnson, T. Carithers, H. A. Taylor Jr., M. L. Bogle, and K. L. Tucker Total {alpha}-Tocopherol Intakes Are Associated with Serum {alpha}-Tocopherol Concentrations in African American Adults J. Nutr., October 1, 2007; 137(10): 2297 - 2303. [Abstract] [Full Text] [PDF]

				T. J. Sontag and R. S. Parker Influence of major structural features of tocopherols and tocotrienols on their {omega}-oxidation by tocopherol-{omega}-hydroxylase J. Lipid Res., May 1, 2007; 48(5): 1090 - 1098. [Abstract] [Full Text] [PDF]

				M. G Traber Heart disease and single-vitamin supplementation Am. J. Clinical Nutrition, January 1, 2007; 85(1): 293S - 299S. [Abstract] [Full Text] [PDF]

				A. J Clifford, F. F de Moura, C. C Ho, J. C Chuang, J. Follett, J. G Fadel, and J. A Novotny A feasibility study quantifying in vivo human {alpha}-tocopherol metabolism Am. J. Clinical Nutrition, December 1, 2006; 84(6): 1430 - 1441. [Abstract] [Full Text] [PDF]

				S. Fairus, R. M Nor, H. M Cheng, and K. Sundram Postprandial metabolic fate of tocotrienol-rich vitamin E differs significantly from that of {alpha}-tocopherol. Am. J. Clinical Nutrition, October 1, 2006; 84(4): 835 - 842. [Abstract] [Full Text] [PDF]

				E. S Ford, R. L Schleicher, A. H Mokdad, U. A Ajani, and S. Liu Distribution of serum concentrations of {alpha}-tocopherol and {gamma}-tocopherol in the US population. Am. J. Clinical Nutrition, August 1, 2006; 84(2): 375 - 383. [Abstract] [Full Text] [PDF]

				D. Q Pham and R. Plakogiannis Vitamin E Supplementation in Cardiovascular Disease and Cancer Prevention: Part 1 Ann. Pharmacother., November 1, 2005; 39(11): 1870 - 1878. [Abstract] [Full Text] [PDF]

				A. R. Proteggente, R. Turner, J. Majewicz, G. Rimbach, A. M. Minihane, K. Kramer, and J. K. Lodge Noncompetitive Plasma Biokinetics of Deuterium-Labeled Natural and Synthetic {alpha}-Tocopherol in Healthy Men with an apoE4 Genotype J. Nutr., May 1, 2005; 135(5): 1063 - 1069. [Abstract] [Full Text] [PDF]

				R. S Bruno, R. Ramakrishnan, T. J Montine, T. M Bray, and M. G Traber {alpha}-Tocopherol disappearance is faster in cigarette smokers and is inversely related to their ascorbic acid status Am. J. Clinical Nutrition, January 1, 2005; 81(1): 95 - 103. [Abstract] [Full Text] [PDF]

				Q. Jiang, J. Wong, H. Fyrst, J. D. Saba, and B. N. Ames {gamma}-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis PNAS, December 21, 2004; 101(51): 17825 - 17830. [Abstract] [Full Text] [PDF]

				J. M. Jordan, A. J. De Roos, J. B. Renner, G. Luta, A. Cohen, N. Craft, C. G. Helmick, M. C. Hochberg, and L. Arab A Case-Control Study of Serum Tocopherol Levels and the Alpha- to Gamma-Tocopherol Ratio in Radiographic Knee Osteoarthritis: The Johnston County Osteoarthritis Project Am. J. Epidemiol., May 15, 2004; 159(10): 968 - 977. [Abstract] [Full Text] [PDF]

				W. L Stone, I. LeClair, T. Ponder, G. Baggs, and B. B. Reis Infants discriminate between natural and synthetic vitamin E Am. J. Clinical Nutrition, April 1, 2003; 77(4): 899 - 906. [Abstract] [Full Text] [PDF]

				R. Brigelius-Flohe, F. J Kelly, J. T Salonen, J. Neuzil, J.-M. Zingg, and A. Azzi The European perspective on vitamin E: current knowledge and future research Am. J. Clinical Nutrition, October 1, 2002; 76(4): 703 - 716. [Abstract] [Full Text] [PDF]

				C. Lauridsen, H. Engel, S. K. Jensen, A. M. Craig, and M. G. Traber Lactating Sows and Suckling Piglets Preferentially Incorporate RRR- over All-rac-{alpha}-Tocopherol into Milk, Plasma and Tissues J. Nutr., June 1, 2002; 132(6): 1258 - 1264. [Abstract] [Full Text] [PDF]

				S. Ikeda, T. Tohyama, and K. Yamashita Dietary Sesame Seed and Its Lignans Inhibit 2,7,8-Trimethyl- 2(2'-carboxyethyl)-6-hydroxychroman Excretion into Urine of Rats Fed {gamma}-Tocopherol J. Nutr., May 1, 2002; 132(5): 961 - 966. [Abstract] [Full Text] [PDF]

				S. W Leonard, Y. Terasawa, R. V Farese Jr, and M. G Traber Incorporation of deuterated RRR- or all-rac-{alpha}-tocopherol in plasma and tissues of {alpha}-tocopherol transfer protein-null mice Am. J. Clinical Nutrition, March 1, 2002; 75(3): 555 - 560. [Abstract] [Full Text] [PDF]

				F. Violi, F. Micheletta, and L. Iuliano Antioxidants and atherosclerosis Eur. Heart J. Suppl., March 1, 2002; 4(suppl_B): B17 - B21. [Abstract] [PDF]

				Q. Jiang, S. Christen, M. K Shigenaga, and B. N Ames {gamma}-Tocopherol, the major form of vitamin E in the US diet, deserves more attention Am. J. Clinical Nutrition, December 1, 2001; 74(6): 714 - 722. [Abstract] [Full Text]

				S. Ikeda, K. Toyoshima, and K. Yamashita Dietary Sesame Seeds Elevate {alpha}- and {gamma}-Tocotrienol Concentrations in Skin and Adipose Tissue of Rats Fed the Tocotrienol-Rich Fraction Extracted from Palm Oil J. Nutr., November 1, 2001; 131(11): 2892 - 2897. [Abstract] [Full Text] [PDF]

				F. Visioli Effects of vitamin E on the endothelium: equivocal? {alpha}-tocopherol and endothelial dysfunction Cardiovasc Res, August 1, 2001; 51(2): 198 - 201. [Full Text] [PDF]

				M. K Horwitt Critique of the requirement for vitamin E Am. J. Clinical Nutrition, June 1, 2001; 73(6): 1003 - 1005. [Abstract] [Full Text] [PDF]

				E. A. Meagher, O. P. Barry, J. A. Lawson, J. Rokach, and G. A. FitzGerald Effects of Vitamin E on Lipid Peroxidation in Healthy Persons JAMA, March 7, 2001; 285(9): 1178 - 1182. [Abstract] [Full Text] [PDF]

				E. M. Lonn, S. Yusuf, V. Dzavik, C. I. Doris, Q. Yi, S. Smith, A. Moore-Cox, J. Bosch, W. A. Riley, and K. K. Teo Effects of Ramipril and Vitamin E on Atherosclerosis : The Study to Evaluate Carotid Ultrasound Changes in Patients Treated With Ramipril and Vitamin E (SECURE) Circulation, February 20, 2001; 103(7): 919 - 925. [Abstract] [Full Text] [PDF]

				Y. Terasawa, Z. Ladha, S. W. Leonard, J. D. Morrow, D. Newland, D. Sanan, L. Packer, M. G. Traber, and R. V. Farese Jr. Increased atherosclerosis in hyperlipidemic mice deficient in alpha -tocopherol transfer protein and vitamin E PNAS, November 22, 2000; (2000) 240462697. [Abstract] [Full Text]

				Q. Jiang, I. Elson-Schwab, C. Courtemanche, and B. N. Ames gamma -Tocopherol and its major metabolite, in contrast to alpha -tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells PNAS, September 22, 2000; (2000) 200357097. [Abstract] [Full Text]

				H. J Kayden and T. Wisniewski On the biological activity of vitamin E Am. J. Clinical Nutrition, July 1, 2000; 72(1): 201 - 202. [Full Text]

				G. T Vatassery, T. Bauer, and M. Dysken Reply to HJ Kayden and T Wisniewski Am. J. Clinical Nutrition, July 1, 2000; 72(1): 202 - 203. [Full Text]

				I. Jialal, S. Devaraj, and S. Yusuf Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients N. Engl. J. Med., June 22, 2000; 342(25): 1917 - 1918. [Full Text]

				K. Kaneko, C. Kiyose, T. Ueda, H. Ichikawa, and O. Igarashi Studies of the metabolism of {alpha}-tocopherol stereoisomers in rats using [5-methyl-14C]SRR- and RRR-{alpha}-tocopherol J. Lipid Res., March 1, 2000; 41(3): 357 - 367. [Abstract] [Full Text]

				J. K. Lodge, M. G. Traber, A. Elsner, and R. Brigelius-Flohé A rapid method for the extraction and determination of vitamin E metabolites in human urine J. Lipid Res., January 1, 2000; 41(1): 148 - 154. [Abstract] [Full Text]

				G. T Vatassery, T. Bauer, and M. Dysken High doses of vitamin E in the treatment of disorders of the central nervous system in the aged Am. J. Clinical Nutrition, November 1, 1999; 70(5): 793 - 801. [Abstract] [Full Text] [PDF]

				R. BRIGELIUS-FLOHÉ and M. G. TRABER Vitamin E: function and metabolism FASEB J, July 1, 1999; 13(10): 1145 - 1155. [Abstract] [Full Text]

				J. E. Swanson, R. N. Ben, G. W. Burton, and R. S. Parker Urinary excretion of 2,7,8-trimethyl-2-(ß-carboxyethyl)-6-hydroxychroman is a major route of elimination of {gamma}-tocopherol in humans J. Lipid Res., April 1, 1999; 40(4): 665 - 671. [Abstract] [Full Text]

				M. K Horwitt My valedictory on the differences in biolog-ical potency between RRR-{alpha}-tocopheryl and all-rac-{alpha}-tocopheryl acetate Am. J. Clinical Nutrition, February 1, 1999; 69(2): 341 - 342. [Full Text] [PDF]

				W. Cohn Evaluation of vitamin E potency Am. J. Clinical Nutrition, January 1, 1999; 69(1): 156 - 157. [Full Text] [PDF]

				G. W Burton, K. U Ingold, M. G Traber, and H. J Kayden Reply to W Cohn Am. J. Clinical Nutrition, January 1, 1999; 69(1): 157 - 158. [Full Text] [PDF]

				Q. Jiang, I. Elson-Schwab, C. Courtemanche, and B. N. Ames gamma -Tocopherol and its major metabolite, in contrast to alpha -tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells PNAS, October 10, 2000; 97(21): 11494 - 11499. [Abstract] [Full Text] [PDF]

				Y. Terasawa, Z. Ladha, S. W. Leonard, J. D. Morrow, D. Newland, D. Sanan, L. Packer, M. G. Traber, and R. V. Farese Jr. Increased atherosclerosis in hyperlipidemic mice deficient in alpha -tocopherol transfer protein and vitamin E PNAS, December 5, 2000; 97(25): 13830 - 13834. [Abstract] [Full Text] [PDF]